Stop overselling GM on yield, warns plant breeding researcher
By Claire Robinson,
GMWatch
| 09. 26. 2023
Photo by Shuken Nakamura on Unsplash
A young researcher studying plant breeding for her PhD at Cornell University has just published a paper warning GMO promoters not to make overhyped claims about supposed yield gains from GM crops. Merritt Khaipho-Burch is the first author on the new publication, called “Genetic modification can improve crop yields — but stop overselling it”.
Khaipho-Burch initially made her case on Twitter last year, comprehensively debunking papers published in Science Magazine reporting massive yield gains from genetic engineering in rice and soybean plants. The click-bait claims made by Science about these papers were lapped up uncritically by the mainstream media, leading Khaipho-Burch to condemn both papers as “misleading” and former Science Magazine reporter Michael Balter to accuse the journal of being “way too credulous” in certain topic areas of science, such as GMO research.
Now Khaipho-Burch and her co-authors have taken the discussion to a higher level, in the form of a peer-reviewed paper in the world’s leading multidisciplinary science journal, Nature, which drives home many points that GMWatch has been making for years...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...